Lupus

Article	Citations
Polyneuritis cranialis as a unique initial presentation of juvenile systemic lupus erythematosus: Case report	61
Prevalence, clinical features, and possible associated factors of mesenteric vasculitis occurrence in patients with systemic lupus erythematosus: An age-, year-at SLE diagnosis, and disease duration-c	45
Application of Bayesian statistics to support approval of intravenous belimumab in children with systemic lupus erythematosus in the United States	36
Intestinal involvement in lupus: From pathophysiology to therapeutic perspectives	23
Neuropsychiatric manifestations are associated with increased mortality in Indian patients with lupus: A single centre retrospective observational study	23
Associations between blood IL-33 levels and IL-33 gene polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis	22
Severe infections in patients with systemic lupus erythematosus from Tunisia: Prevalence and risk factors	20
Analysis of 5-year hospitalization data of patients with systemic lupus erythematosus: Damage is a risk factor for frequent and longer stays	19
The correlation between pregnancy, disease activity and adverse pregnancy outcomes in patients with systemic lupus erythematosus	18
The challenges in diagnosing pediatric primary antiphospholipid syndrome	18
Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids	17
Long COVID in patients with systemic lupus erythematosus: A case-control study	17
Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study	16
Optical coherence tomography angiography findings of systemic lupus erythematosus patients and the effect of neuropsychiatric involvement on it	16
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey	15
Investigating the role of IL-6 in the pathogenesis of systemic lupus erythematosus: Insights from bone marrow mesenchymal stem cells	15
Cardiac magnetic resonance feature tracking evaluates left atrial strain in patients with systemic lupus erythematosus and mitral regurgitation	15
Lymphoid interstitial pneumonia in a patient with systemic lupus erythematosus: Case report and literature review	15
Naomi Rothfield, MD, MACR 1929-2023	15
Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations	15
Systemic lupus international collaborating clinics-2012 and European league against rheumatism/American college of rheumatology-2019 classification criteria for systemic lupus erythematosus associated	15
Nationwide analysis of childhood-onset systemic lupus erythematosus mortality in Mexico, 2000–2023	15
A qualitative investigation of the experiences of patients living with antiphospholipid antibodies	14
Obinutuzumab in patients with repeated lupus nephritis flares: A case series	14
Reversible dilated cardiomyopathy in systemic lupus erythematosus: A case report	14

Impact of SARS-CoV-2 variants infection on mid- and long-term outcomes in Puerto Ricans with systemic lupus erythematosus: Two-year follow-up	13
Growth arrest-specific protein 6 as a marker of nephritis in systemic sclerosis and juvenile systemic lupus erythematosus patients	13
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort	13
Electronic health record data use in the assessment of quality indicators for glucocorticoid osteoporosis screening in systemic lupus erythematosus	13
Depression in systemic lupus erythematosus: A manifestation of microcirculation dysfunction?	13
Thanks to Reviewers	13
Exploring the role of LIAS-related cuproptosis in systemic lupus erythematosus	13
Considering belimumab during pregnancy: A more viable option over time	12
Targeting systemic lupus erythematosus (SLE) using Withania somnifera derived compounds: A network and molecular dynamics study	12
An ecological approach to understanding and addressing health inequities of systemic lupus erythematosus	12
Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study	12
Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort	12
Bone microarchitecture impairment in juvenile systemic lupus erythematosus patients: A comparative study	12
Prevalence of migraine in systemic lupus erythematosus: A meta-analysis	12
Repeat kidney biopsy findings of lupus nephritis patients in clinical remission treated with Mycophenolate associated with Belimumab or Mycophenolate plus standard of care therapy. A “post-hoc” analys	11
DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies	11
Diagnostic and clinical implications of PARP9 promoter methylation in systemic lupus erythematosus and rheumatoid arthritis	11
Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses	11
Calcineurin inhibitors for initial induction treatment of lupus nephritis in children	11
The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study	11
Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients	11
Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis	10
Level of CD4 + central memory T cells and its clinical correlation in childhood-onset systemic lupus erythematosus	10
Does the standard proteinuria cut-off for renal biopsy in lupus nephritis as per the current guidelines hold good for Asian population? A single-centre study from South India	10
Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus	10
The (reverse) paradox of lupus anticoagulant: A case report	10
Real-world treatment patterns of immunosuppressants in Adults with systemic lupus erythematosus: A claims database analysis in the United States	10
The Type 1 & 2 systemic lupus erythematosus model: Perspectives of people living with systemic lupus erythematosus	10
Steroid-free flare management of a severe cutaneous lupus flare with anifrolumab	10
Dietary patterns and life-styles of patients with gastrointestinal involvement of systemic lupus erythematosus: Questionnaire survey from a tertiary center of China	10
Thrombocytopenia in systemic lupus erythematosus real-world insights from the nationwide RISE database	9
Factors mediating cancer risk in systemic lupus erythematosus	9
Estimating glucocorticoid-related morbidity in lupus nephritis using the glucocorticoid toxicity index	9
Systemic lupus erythematosus and antiphospholipid syndrome with retiform purpura as the initial skin lesion: A case study	9
KRAS-associated pediatric lupus: Expanding the genomic landscape of monogenic lupus	9
Shrinking lung syndrome in systemic lupus erythematosus: Insights from a case series and a systematic review of the past decade	9
Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis	9
“Long COVID in patients with systemic lupus erythematosus: A case‒control study”—a methodological consideration	9
Lupus podocytopathy: A systematic review of clinical evidence from cases and cohorts	9
Risk stratification for infection during immunosuppressive therapy in patients with lupus nephritis: A nested case-control study	9
Association between cognitive impairment and olfactory deficits in systemic lupus erythematosus without major neuropsychiatric syndromes	9
Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey	9
Downregulation of circETS1 disrupts Th17/Treg homeostasis by inhibiting FOXP3 transcription: A new potential biomarker in systemic lupus erythematosus	9
Systemic lupus erythematosus with diffuse intracranial calcification: A case report and review of literature	9
Reduced circulating Tregs and positive pANCA were robustly associated with the occurrence of antiphospholipid syndrome in patients with systemic lupus erythematosus	9
Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome	9
The many faces of an (In)visible disease: Rethinking rarity in lupus	9
Epidemiology and outcomes of emergency department visits in systemic lupus erythematosus: Insights from the nationwide emergency department sample (NEDS)	9
A 5–year follow-up of pulmonary function tests in childhood-onset systemic lupus erythematosus: a single-center retrospective study	9
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort	9

Induction treatment for lupus nephritis at a high-complexity hospital in Chile	9
T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain as a promising immune checkpoint target for the treatment of SLE	8
Long-term outcome and predictors of long-term outcome in patients with lupus nephritis managed at a tertiary hospital in Mumbai	8
Adherence patterns to medications and their association with subsequent hospitalization in adult Egyptian patients with systemic lupus erythematosus	8
Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness	8
Research progress in functional magnetic resonance imaging assessment of lupus nephritis kidney injury	8
Correspondence on “relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus” by Chi Chiu Mok et al	8
Disease exacerbation and COVID-19 following mRNA COVID-19 vaccination in adolescents with Systemic Lupus Erythematosus	8
Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register	8
Gut and oral microbiota characterized in systemic lupus erythematosus patients from India: A pilot study	8
Factors associated with medication adherence among patients with systemic lupus erythematosus: A systematic review	8
Real-world glucocorticoid prescription patterns in patients with lupus nephritis: A retrospective study using a healthcare insurance claims database	8
Proportion, domains, and risk factors of cognitive impairment in systemic lupus erythematosus	8
Omega-3 fatty acids: Current insights into mechanisms of action in systemic lupus erythematosus	8
Association between interstitial fibrosis/tubular atrophy (IFTA) on kidney biopsies and anti Ro60 antibody positivity in patients with lupus nephritis (LN)	8
Higher body mass index and disease duration are associated with increased risk of left ventricular diastolic dysfunction in women with systemic lupus erythematosus	8
Predictors of long-term renal survival and mortality in patients with proliferative and membranous lupus nephritis	8
Progenitor cells and circulating endothelial cells are associated with disease activity and damage in systemic lupus erythematosus patients	8
Patient-reported outcome measures in patients with systemic lupus erythematosus with or without concurrent fibromyalgia	8
A novel long noncoding RNA ENST00000597482 serves as a potential biomarker for disease activity and diagnosis of systemic lupus erythematosus	8
Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience	8
Membranous lupus nephritis secondary to secukinumab therapy: A case report and literature review	8
Impact of hydroxychloroquine on pregnancy outcomes in systemic lupus erythematosus: A 25 years retrospective cohort study from Asia	8
Definition and application of systemic lupus erythematosus disease modification in emerging markets: Delphi panel consensus recommendations	8
Lupus nephritis and pregnancy: Diagnosis, prognosis, and management	8
The effect of community-acquired pneumonia on myocardial injury in systemic lupus erythematosus: Insights from cardiac magnetic resonance	7
A high level of sTREM-1 predicts occurrence of thrombosis, obstetrical event or death in a prospective cohort of patients with antiphospholipid antibodies and/or systemic lupus. Results of the APLART	7
Non-invasive prediction of the chronic degree of lupus nephropathy based on ultrasound radiomics	7
Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis	7
Regarding the efficacy of the COVID-19 vaccine in pediatric systemic lupus erythematosus patient	7
Determinants of sexual function in male patients with systemic lupus erythematosus	7
A single-center model for implementation of SLEDAI documentation adherence in childhood-onset systemic lupus erythematosus (cSLE)	7
Primary antiphospholipid syndrome with and without limb ischemia: A retrospective observational study	7
A rare case of late-onset spondyloenchondrodysplasia with immune dysregulation presenting as adult-onset monogenic lupus	7
Predictive model of risk and severity of enteritis in systemic lupus erythematosus	7
Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII	7
Systemic lupus erythematosus-related acute lung disease	7
Healthcare costs of systemic lupus erythematosus in New Zealand	7
Epstein-Barr virus infection and its association with systemic lupus erythematosus: Systematic review and meta-analysis	7
Evaluation of thyroid dysfunction in childhood-onset systemic lupus erythematosus: Risk factors for Hashimoto’s thyroiditis	7
Premature ovarian failure in juvenile systemic lupus erythematosus patient: A rare presentation	7
Network pharmacology and molecular docking to elucidate the common mechanism of hydroxychloroquine treatment in lupus nephritis and IgA nephropathy	7
Oral lesions of systemic lupus erythematosus: A collaborative Latin American study	7
Clinical, serological, and targeted genetic analysis of systemic lupus erythematosus in Kazakhstan	7
Severe gastrointestinal manifestations in childhood-onset lupus: A single-center cohort and review of the literature	7
Cytomegalovirus infection and disease in systemic lupus erythematosus patients at a high-complexity hospital in southwestern Colombia	7
Long-term steroid-sparing effect of belimumab in systemic lupus erythematosus: Post hoc pooled analysis of OBSErve multi-country cohort data	6
Treatment adherence and quality of life in colombian patients with lupus nephritis	6
Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus	6
Intravenous immunoglobulin as a treatment for severe, refractory cutaneous lupus erythematosus requiring hospitalization: Three cases and review of the literature	6
Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch	6
Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study	6
Drug-induced lupus erythematosus in childhood: Case-based review	6
Cytomegalovirus infection and its association with systemic lupus erythematosus: Systematic review and meta-analysis	6
Reconsidering cutaneous lupus erythematosus of the elbows: Evidence for polymorphous light eruption	6
Detection of genetic mutations underlying early-onset systemic lupus erythematosus	6
Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus	6
Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus	6
Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis	6
Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications	6
Efficacy and safety of telitacicept in the treatment of systemic lupus erythematosus: A retrospective real-world study	6
Retrospective cohort study identifying pulmonary complications in a cohort of patients with systemic lupus erythematosus	6
Evaluating the performance of four anti-dsDNA antibody detection methods	6
Life expectancy and death pattern associated with systemic lupus erythematosus diagnosis in Brazil between 2000 and 2019	6
Serum long non-coding Ribonucleic Acid H19 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression	6
Real world application of the 2023 ACR/EULAR antiphospholipid antibody syndrome classification criteria in a pharmacist directed anticoagulation clinic	6
Early diagnosis of lupus: A possibilty. A multicentric study from SLE Special Interest Group (SIG) of Indian Rheumatology Association (IRA)	6
Phenotype and disease course differences in monogenic and sporadic childhood lupus	5
Chorea associated with systemic lupus erythematosus- a systematic review	5
Abnormal presentation of pregnancy and postpartum initial-onset systemic lupus erythematosus combined with diffuse alveolar hemorrhage: A case report	5
Trends in all-cause hospitalizations for systemic lupus erythematosus in Mexico, 2000–2019	5
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study	5
Diving deep into lupus: Gastrointestinal involvement insights from the Oman lupus study	5
Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome	5
Ablation of SigH+ pDCs in B6.Nba2 mice prevents lupus-like disease development only if started before disease is fully established	5
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance	5
Association of CTLA-4 exon 1(+49 A/G) polymorphism and susceptibility to SLE in Egyptian children and adolescents	5
Exploring prefrontal alpha modulation as a mechanistic treatment target in lupus-associated depression: A transcranial alternating current stimulation study	5
Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients	5
Parkinsonism as the presenting manifestation of lupus: A case-based review	5

Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares	5
Serological activity in clinically quiescent SLE: To treat or not to treat in the biologic era?	5
APOL1 and the risk of adverse renal outcomes in patients of African ancestry with systemic lupus erythematosus	5
The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study	5
Risk factors for cytomegalovirus reactivation and disease in patients with systemic lupus erythematosus	5
Development and psychometric properties of the Reproductive Health Assessment in Systemic Lupus Erythematosus: Mixed-Methods study	5
The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: A systematic review	5
Clinical efficacy of centrifugal-membranous hybrid double filtration plasmapheresis and membranous double filtration plasmapheresis on severe lupus nephritis	5
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score	5
Skin erythematous migrant lesions consistent with histologically confirmed dermal arteriolar thrombosis connected to APS	5
Utility of pan-immune-inflammation value as a predictor of the prognosis of childhood lupus	5
LncRNA NRIR serves as a biomarker for systemic lupus erythematosus and participates in the disease progression	5
Literature review of lupus nephritis From the Arabian Gulf region	5
Skin and beyond: Demographics, clinical features and systemic involvement of cutaneous lupus erythematosus in Pakistani population	5
Systemic lupus erythematosus and toll-like receptor 9 polymorphisms: A meta-analysis of genetic association studies	5
Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis	5
Comparative efficacy of intravenous cyclophosphamide, mycophenolate mofetil, and tacrolimus as induction therapy for lupus nephritis: A randomized controlled open-label trial	5
Interferon-gamma (IFN-γ) intronic variant (rs2430561) is a risk factor for systemic lupus erythematosus: Observation from a meta-analysis	5
Impact of scalp involvement on disease severity and professional life in patients with cutaneous lupus erythematosus	5
Impact of perception of illness on quality of life in juvenile systemic lupus erythematosus	5
Efficacy of Telitacicept in a systemic lupus erythematosus patient with suboptimal response to Belimumab: A case report	5
Differential glomerular expression patterns of Th17-related cytokines in Mexican patients with lupus nephritis	5
Bilateral outer foveal microdefect in a patient with systemic lupus erythematosus using hydroxychloroquine - A case report	5
The efficacy of induction treatment in Thai patients with lupus nephritis: Observational cohort analysis	5
What you need to know about migraine in Hughes syndrome patients	5
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in lupus nephritis at Cho Ray hospital, Vietnam	5
Clinicopathologic features in childhood-onset lupus nephritis with antineutrophil cytoplasmic antibody positivity——a multi-center retrospective study	5
The experience and implications of pain in systemic lupus erythematosus: A qualitative interview study focusing on the patient’s perspective	5
Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients	5
Lupus anticoagulant-hypoprothrombinemia syndrome in children: Three case reports and systematic review of the literature	4
Delayed onset of systemic lupus erythematosus in patients with idiopathic membranous nephropathy	4
Evaluation of thiol/disulfide hemostasis and serum Ischemia modified albumin as oxidative stress biomarkers in systemic lupus erythematosus patients: Relationship with major organ involvement and dise	4
Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus	4
Systematic literature review of intravenous immunoglobulin use in non-renal and non-hematologic systemic lupus erytehmatosus	4
Initiation of belimumab with higher daily prednisolone is effective for rapid glucocorticoid reduction: A 96-week retrospective study	4
National epidemiological analysis of lupus in Chile: A registry-based study from 2013 to 2024	4
Hypertension is associated with global and renal damage accrual in patients with systemic lupus erythematosus. Data from the Almenara Lupus Cohort	4
Association between antiphospholipid syndrome and postural orthostatic tachycardia syndrome (POTS)	4
Mrs Denzil Fletcher	4
Correlation between ABO blood group and clinical characteristics of patients with lupus nephritis	4
Impaired serotonin synthesis in hippocampus of murine lupus represents an early neuropsychiatric event	4
Association of systemic lupus erythematosus with clinical and psychosocial outcomes, health care resource utilization and expenditures: A nationally representative US-based analysis	4
Interferon signatures in systemic lupus erythematosus patients across ethnic groups	4
Diffuse alveolar haemorrhage in systemic lupus erythematosus: A multicentre retrospective study in Singapore	4
U-KIM-1 as a predictor of treatment response in lupus nephritis	4
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro	4
Clinical and laboratory differences in pediatric-onset versus adult-onset lupus nephritis: A retrospective cohort analysis	4
Psychological and quality of life effects of vaccination against COVID-19 in patients with systemic autoimmune diseases	4
Subclinical systolic dysfunction by speckle tracking echocardiography in patients with systemic lupus erythematosus	4
Laryngeal and voice dysfunction in systemic lupus erythematosus patients – A case-control study	4
Cost-effectiveness of cyclophosphamide and non-cyclophosphamide in the induction therapy of Malaysian lupus nephritis patients	4
Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus	4
Unilateral lupus mastitis	4
Primary antiphospholipid syndrome in pediatrics: New criteria, new opportunities	4
Using combination of albumin to fibrinogen ratio and prognostic nutritional index model for predicting disease activity in patients with systemic lupus erythematosus	4
Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series	4
Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-Yaa mice	4
Complex relationships between inflammatory manifestations/type 1 and type 2 symptoms in systemic lupus erythematosus: A narrative literature review	4
The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the “Catastrophic antiphospholipid syndrome regis	4
Predictive value of Doppler echocardiography parameters for cardiovascular events in patients with systemic lupus erythematosus	4
A conceptual model of the patient experience of cutaneous lupus erythematosus	4
A review of the development of gangrene in patients with systemic lupus erythematosus – A 44-year follow-up study	4
Frailty in systemic lupus erythematosus:A scoping review	4
CAR-modified cells and the sisyphus myth: A new panacea for lupus?	4
Peripheral mononuclear cells and systemic lupus erythematosus association: Integrated study of single-cell sequencing and mendelian randomization analysis	4
Machine learning: Predicting hospital length of stay in patients admitted for lupus flares	4
Risk factors analysis and risk assessment model construction of systemic lupus erythematosus patients with infection	4
Neutrophilic dermatoses as a manifestation of a systemic lupus erythematosus flare	4
Clinical features of anti-ribosomal P protein antibodies in systemic lupus erythematosus: A single-center retrospective study in China	4
Increased frequency of hospital admissions with active systemic lupus erythematosus disease activity defined by two different disease activity indices: A cohort study	4
Choroidal thickness in active lupus nephritis	4
Serum pentraxin 3 in systemic lupus erythematosus: A potential indicator of cutaneous disease activity	4
Incidence and prevalence of systemic lupus erythematosus in New Zealand from the national administrative datasets	4
Treatment patterns in patients with systemic lupus erythematosus in New Zealand	4